Resequencing and association analysis of MIR137 with schizophrenia in a Japanese population

Psychiatry and Clinical Neurosciences

Volumn 67, Issue 4, 2013, Pages 277-279

  Egawa, Jun ^a,b   Nunokawa, Ayako ^a,c   Shibuya, Masako ^a,d   Watanabe, Yuichiro ^a,e   Kaneko, Naoshi ^a,f   Igeta, Hirofumi ^a   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b National Saigata Medical Center   (Japan)

^c Niigata Psychiatric Center   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f Oojima Hospital   (Japan)

Author keywords

MIR137; resequencing; schizophrenia; single nucleotide variation; variable number of tandem repeats

Indexed keywords

MICRORNA; MIR 137; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTRON; JAPANESE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; RISK ASSESSMENT; SCHIZOPHRENIA;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; MICRORNAS; SCHIZOPHRENIA;

EID: 84877931464     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12047     Document Type: Article

References (9)

1. Schratt G,. microRNAs at the synapse. Nat. Rev. Neurosci. 2009; 10: 842-849.
2. Beveridge NJ, Cairns MJ,. MicroRNA dysregulation in schizophrenia. Neurobiol. Dis. 2012; 46: 263-271.
3. Smrt RD, Szulwach KE, Pfeiffer RL, et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 2010; 28: 1060-1070.
4. Ripke S, Sanders AR, Kendler KS, et al. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011; 43: 969-976.
5. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T,. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr. Res. 2006; 84: 29-35.
6. Nunokawa A, Watanabe Y, Kaneko N, et al. The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case-control studies and an updated meta-analysis. Schizophr. Res. 2010; 116: 61-67.
7. Bemis LT, Chen R, Amato CM, et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res. 2008; 68: 1362-1368.
8. Xu B, Ionita-Laza I, Roos JL, et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 2012; 44: 1365-1369.
9. Bergen SE, O'Dushlaine CT, Ripke S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol. Psychiatry 2012; 17: 880-886.